VIOLET GILBERT: Open Payments
NPI 1346657392 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 46 payments from 9 companies in 2025. Trend: 2023 $337 · 2024 $564 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $277 |
| ABBVIE INC. | 13 | $228 |
| Alkermes, Inc. | 2 | $140 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, LYBALVI, Auvelity, INGREZZA, AUSTEDO XR, FANAPT, REXULTI.
Industry payments across AL — which companies pay providers there.
